Enzyme Finance

Asset managers running strategies across centralized exchanges, DeFi protocols, and multiple wallets face a critical challenge: accurate reporting. Inconsistent data sources make it difficult to provide reliable valuations to investors. **The Solution** Enzyme has partnered with [1Token](https://enzyme.finance/blog-posts/enzyme-and-1token-partnership?utm_source=x&utm_medium=organic&utm_content=post) to address this problem: - Reconciles data from both CeFi and DeFi sources - Provides unified valuation across multiple venues - Helps managers maintain investor confidence through transparent reporting This follows Enzyme's recent integration with Octav, showing a pattern of building infrastructure for cross-chain and multi-venue asset management. **Why It Matters** As crypto strategies become more complex, spanning different chains and platforms, accurate position tracking becomes essential for institutional adoption and investor trust.

On-chain spot markets are narrowing the price gap with traditional venues while maintaining self-custody and instant settlement advantages. **Key developments:** - Capital efficiency improving through faster block times and enhanced execution infrastructure - Trading volume expanding as tooling matures - Institutional participants now actively monitoring the space **Market context:** This follows 3x year-over-year growth in USDC's share of spot trading volume through September 2025. Stablecoins are increasingly powering settlement and providing 24/7 market liquidity beyond traditional banking hours. The shift represents a tangible evolution from theoretical concepts to operational reality in capital markets infrastructure.

**Enzyme Onyx** addresses different protocol needs across three key stages: - **Pre-TGE**: Early participation incentives to build community - **Post-TGE**: Strengthen Total Value Locked (TVL) after token launch - **Mature stage**: Manage liquidity across multiple assets including stablecoins and liquid staking tokens The platform provides structured, on-chain strategies that protocols can adopt when timing is right for their development phase. Each stage requires different tooling approaches, but most protocols eventually need comprehensive on-chain financial infrastructure. [Explore Onyx](https://enzyme.finance/products/onyx?utm_source=x&utm_medium=organic&utm_content=post)

**Multi-chain complexity solved**: As investment products expand across different blockchains, reporting becomes increasingly complex for asset managers. **Automated data sourcing**: Chainlink's CRE (Crypto Reporting Engine) automatically pulls and verifies NAV and performance data from: - On-chain sources - Centralized finance platforms - Traditional financial systems **Pain point addressed**: The solution eliminates manual reporting work that previously required tracking assets across multiple chains and platforms. **Verification built-in**: All data is automatically verified, reducing errors and ensuring accuracy for compliance and investor reporting.

Enzyme.Myso is advancing DeFi with institutional-grade on-chain options trading. The platform offers: - Native on-chain options strategies - Fully auditable transaction flows - Infrastructure designed for DAOs and institutions **Real-world implementation**: Compound DAO recently integrated covered calls into their treasury strategy using Enzyme.Myso, targeting approximately 15% APY while maintaining controlled risk exposure. This development signals a shift in how DAOs can optimize idle capital through sophisticated options strategies. *Learn more at* [Enzyme Finance](http://enzyme.finance/products/myso)

Major financial institutions are forecasting significant growth in tokenized assets: - Citi projects tokenized securities market could reach $45T by 2030 - WEF estimates 10% of global GDP could be blockchain-tokenized by 2027 - McKinsey reports shift from pilot to at-scale deployment Key trends expected in next cycle: - Shift to natively tokenized funds - Increased institutional adoption - Integration with DeFi infrastructure - Clearer regulatory framework Traditional finance faces challenges from outdated systems, while tokenized vehicles offer programmability and global accessibility. Enzyme Protocol is positioning to support this transition with native tokenization capabilities. [Learn more about tokenized funds](http://enzyme.finance/use-cases/tokenized-funds)

Real-world assets (RWAs) tokenized on blockchain have reached a significant milestone, surpassing $10B in Total Value Locked (TVL). This marks a crucial shift in how traditional assets are being brought on-chain. Key developments: - Over $18B in assets now tokenized (excluding stablecoins) - Infrastructure development becoming priority for operational use - Integration possibilities include RWA funds, ETPs, and indices Enzyme Protocol enables users to leverage these tokenized assets within investment strategies, marking a practical step toward mainstream RWA adoption. Learn more about tokenized asset infrastructure: [Chainlink's Guide](https://blog.chain.link/definitive-guide-to-tokenized-assets/)

Enzyme Protocol marked significant expansion in 2024 with key developments: - Acquired Myso Finance, the leading on-chain covered calls protocol - Invested in Trade Neutral to expand services to Solana ecosystem - Extended protocol to Arbitrum and integrated GMX - Launched first Advanced Automated Loops with Stader Labs - Reached $220M in Assets Under Technology with 1,400+ creations 2025 roadmap focuses on: - Completing Solana integration - Expanding to additional networks - Launching V5 protocol update - Strengthening global infrastructure position The protocol has maintained steady growth since its 2017 launch as Melon Protocol, navigating market cycles while expanding capabilities.

Enzyme Protocol continues to expand its ecosystem with the addition of new vaults: - **VaultCraft.io** launched a new vault on Enzyme, offering users more investment options. - **Renzo Protocol** introduced a vault powered by Enzyme and curated by Re7 Capital. These developments demonstrate Enzyme's growing popularity in the decentralized asset management space. Users now have access to a wider range of on-chain investment vehicles, each with unique strategies and management approaches. *Interested in exploring these new vaults?* Visit Enzyme's platform to learn more about the offerings and consider diversifying your portfolio.